6 results  1 of 1 

1 Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus
Kun-Ho Yoon, Elise Hardy, Jenny Han
Diabetes Metab J.2017;41(1):69-74.   Published online 2016 December 26     DOI: http://dx.doi.org/10.4093/dmj.2017.41.1.69
2 Effects of Exendin-4 on Male Reproductive Parameters of D-Galactose Induced Aging Mouse Model
Akram Ahangarpour, Ali Akbar Oroojan, Hamid Heidari
World J Mens Health.2014;32(3):176-183.   Published online 2014 December 29     DOI: http://dx.doi.org/10.5534/wjmh.2014.32.3.176
3 A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth
Hee Young Kim, Jong-Ik Hwang, Mi Jin Moon, Jae Young Seong
Endocrinol Metab.2014;29(3):320-327.   Published online 2014 September 25     DOI: http://dx.doi.org/10.3803/EnM.2014.29.3.320
4 Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Young Min Cho, Rhonda D. Wideman, Timothy J. Kieffer
Endocrinol Metab.2013;28(4):262-274.   Published online 2013 December 12     DOI: http://dx.doi.org/10.3803/EnM.2013.28.4.262
5 Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study
Juyoung Shin, Jin-Sun Chang, Hun-Sung Kim, Sun-Hee Ko, Bong-Yun Cha, Ho-Young Son, Kun-Ho Yoon, Jae-Hyoung Cho
Diabetes Metab J.2012;36(5):364-370.   Published online 2012 October 18     DOI: http://dx.doi.org/10.4093/dmj.2012.36.5.364
6 The Effects of Exendin-4 on IRS-2 Expression and Phosphorylation in INS-1 Cells
Ji-Hyun Kim, Ji-Won Kim, Sung-Yoon Jeon, Heon-Seok Park, Dong-Sik Ham, Young-Hye You, Seung-Hwan Lee, Jae-Hyoung Cho, Mi-Ja Kang, Kang-Woo Lee, Hyuk-Sang Kwon, Kun-Ho Yoon, Bong-Yun Cha, Kwang-Woo Lee, Sung-Koo Kang, Ho-Young Son
Korean Diabetes J.2008;32(2):102-111.   Published online 2008 April 30     DOI: http://dx.doi.org/10.4093/kdj.2008.32.2.102

 1 of 1